The National Foundation for Cancer Research, led by Chairman Joseph F. Franlin and President Sujuan Ba, recruited a delegation of eight U.S. cancer technology start-ups for a successful exploratory mission to China. The companies—ArrayBio, Eutropics, Immix Biopharma, InterLeukin Therapeutics, International Cancer Impact Fund, InVaMet Therapeutics,...
The Society for Neuro-Oncology of China has invited Dr. Sujuan Ba, the president and chief operating officer of the National Foundation for Cancer Research (NFCR), to give a lecture at its annual meeting, SNOChina 2018, to be held in Changsha, Hunan on March 16-17, 2018. ...
This year, cancer research is moving at an exciting pace towards a real transformation. Just last month, the U.S. Food and Drug Administration approved a cancer treatment based on a biomarker rather than the body location where the cancer originates. ...
NFCR President receives the inaugural award from Society for Neuro-Oncology of the Chinese Medical Doctor Association for her outstanding contribution to international cooperation in March 2017. [caption id="attachment_13570" align="aligncenter" width="486"] From left to right: Wenbin, Li, Tao Jiang, Sujuan Ba, Webster Cavenee[/caption] Dr. Jiang Tao, the Chairman...
Dr. Web Cavenee and Dr. Paul B. Fisher discover a new pharmacological agent to treat glioblastoma multiforme (GBM), the deadliest brain cancer....
NFCR President and COO, Dr. Sujuan Ba, has spent this past year traveling the world to lead efforts and collaborate with top scientists. Read about some of the conferences, people and successes in 2016....
The National Foundation is deeply honored and grateful that our mission of cancer research to find new and better ways to prevent, diagnose and treat all types of cancer was supported and valued by Barbara Karpouzis Valavanes....
Search NFCR
Popular searches